SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001485003-21-000157
Filing Date
2021-07-21
Accepted
2021-07-21 17:33:21
Documents
4
Period of Report
2021-07-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_162690318761334.html 3  
1 FORM 3 wf-form3_162690318761334.xml 3 1713
2 PETER HONIG POA sesn-poaforphonigconform.htm EX-24 4128
3 HONIG - JPEG 1 sesn-poaforphonigconform001.jpg GRAPHIC 221040
4 HONIG - JPEG 2 sesn-poaforphonigconform002.jpg GRAPHIC 58406
  Complete submission text file 0001485003-21-000157.txt   392385
Mailing Address 3344 N. TORREY PINES COURT, SUITE 200 LA JOLLA CA 92037
Business Address
Honig Peter (Reporting) CIK: 0001484780 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36296 | Film No.: 211105383

Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Issuer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations